Medicare Contractor Issues Draft Local Coverage Determination for Veracyte Lung Cancer Test | GenomeWeb

NEW YORK (GenomeWeb) – Veracyte announced today that Medicare contractor Palmetto GBA has issued a draft local coverage determination (LCD) for the company's Percepta Bronchial Genomic Classifier.

"As anticipated, we are moving quickly toward securing draft Percepta LCDs from all four [Molecular Diagnostic Services] program participants," Veracyte President and CEO Bonnie Anderson said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.